Bismuth subsalicylate 262 mg / kaolin 500 mg per 15 mL Oral Suspension
RxNorm 1249102
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1249102 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: bismuth subsalicylate 262 mg / kaolin 500 mg per 15 mL Oral Suspension.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
Bismuth subsalicylate 17.5 mg/ML / kaolin 33.3 mg/ML Oral Suspension
(Atom ID: 12345341)
PSN
Prescribable Name (PSN):
Bismuth subsalicylate 262 mg / kaolin 500 mg per 15 mL Oral Suspension
(Atom ID: 8698442)
SY